NO178892C - Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor - Google Patents

Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor

Info

Publication number
NO178892C
NO178892C NO923260A NO923260A NO178892C NO 178892 C NO178892 C NO 178892C NO 923260 A NO923260 A NO 923260A NO 923260 A NO923260 A NO 923260A NO 178892 C NO178892 C NO 178892C
Authority
NO
Norway
Prior art keywords
kedarcidine
chromophore
preparation
well
pharmaceutical composition
Prior art date
Application number
NO923260A
Other languages
English (en)
Norwegian (no)
Other versions
NO178892B (no
NO923260L (no
NO923260D0 (no
Inventor
John E Leet
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO923260D0 publication Critical patent/NO923260D0/no
Publication of NO923260L publication Critical patent/NO923260L/no
Publication of NO178892B publication Critical patent/NO178892B/no
Publication of NO178892C publication Critical patent/NO178892C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO923260A 1991-09-26 1992-08-20 Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor NO178892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/763,465 US5143906A (en) 1991-09-26 1991-09-26 Kedarcidin antitumor chromophore and pharmaceutical composition containing same

Publications (4)

Publication Number Publication Date
NO923260D0 NO923260D0 (no) 1992-08-20
NO923260L NO923260L (no) 1993-03-29
NO178892B NO178892B (no) 1996-03-18
NO178892C true NO178892C (no) 1996-06-26

Family

ID=25067899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923260A NO178892C (no) 1991-09-26 1992-08-20 Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor

Country Status (17)

Country Link
US (1) US5143906A (ref)
EP (1) EP0534137A3 (ref)
JP (1) JPH06179623A (ref)
KR (1) KR930005632A (ref)
CN (1) CN1032235C (ref)
AU (1) AU647300B2 (ref)
CA (1) CA2075453A1 (ref)
FI (1) FI923827A7 (ref)
HU (1) HU211108B (ref)
IL (1) IL102942A0 (ref)
MX (1) MX9204765A (ref)
NO (1) NO178892C (ref)
NZ (1) NZ244149A (ref)
PL (1) PL168918B1 (ref)
RU (1) RU2067117C1 (ref)
TW (1) TW215900B (ref)
ZA (1) ZA926421B (ref)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706729A (en) * 1963-11-21 1972-12-19 Andrew David Batcho Antibiotics and processes for their preparation
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin

Also Published As

Publication number Publication date
FI923827A0 (fi) 1992-08-26
EP0534137A3 (en) 1994-07-06
NO178892B (no) 1996-03-18
IL102942A0 (en) 1993-01-31
ZA926421B (en) 1993-03-01
HUT62908A (en) 1993-06-28
NO923260L (no) 1993-03-29
AU647300B2 (en) 1994-03-17
MX9204765A (es) 1993-03-01
JPH06179623A (ja) 1994-06-28
PL295725A1 (en) 1993-04-05
HU211108B (en) 1995-10-30
CN1032235C (zh) 1996-07-10
RU2067117C1 (ru) 1996-09-27
FI923827L (fi) 1993-03-27
TW215900B (ref) 1993-11-11
PL168918B1 (pl) 1996-05-31
NZ244149A (en) 1994-01-26
AU2080092A (en) 1993-04-01
CA2075453A1 (en) 1993-03-27
KR930005632A (ko) 1993-04-20
FI923827A7 (fi) 1993-03-27
EP0534137A2 (en) 1993-03-31
CN1073447A (zh) 1993-06-23
NO923260D0 (no) 1992-08-20
US5143906A (en) 1992-09-01

Similar Documents

Publication Publication Date Title
DK42093D0 (da) Administrationsmetode
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
KR900700485A (ko) 티에노피리딘, 제조방법, 중간체 및 약제학적 조성물
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
FI942745L (fi) Fluoreeniyhdisteitä ja valmistusmenetelmä
FI945900A7 (fi) Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi
FI954105A7 (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
FI940585L (fi) Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
FI20000516A7 (fi) Bis-indolyylimaleimidijohdannaiset ja niiden valmistus
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
FI934426A7 (fi) Tiatsolidiinidionijohdokset, niiden valmistus ja käyttö
NO950022L (no) Smaksfremmende preparat inneholdende kollidalt silika, samt fremgangsmåte til fremstilling og anvendelse derav
FI943316L (fi) Farmaseuttiset koostumukset, joissa on nifedipiiniä ja menetelmä sen valmistamiseksi
FI935887A7 (fi) Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
BR9200323A (pt) Formulacao de tiol-eno curavel,e sua composicao
DK0562583T3 (da) Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
FI941836A7 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI961521L (fi) Lääkeformulaatioiden valmistusmenetelmä
FI921525A7 (fi) Amidinofenyylialaniinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö ja niitä sisältäviä aineita
FI931232L (fi) Makeutusaine, menetelmä sen valmistamiseksi ja sen käyttö
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
FI923755A7 (fi) Disulfideja, menetelmiä niiden valmistamiseksi ja niiden käyttö
NO303637B1 (no) 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav